Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
H.R. 7085 BIOSECURE ACT; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry.
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry, including descriptions of corporate structure, business units, and data handling.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
WUXI BIOLOGICS USA LLC via WUXI BIOLOGICS USA LLC
2026 · third_quarter · Q3
Lobbying related to Congressional and Administration introductions and company updates, communications related to company operations and CRDMO industry, including descriptions of corporate structure, business units, and data handling.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
WUXI BIOLOGICS USA LLC via WUXI BIOLOGICS USA LLC
2026 · second_quarter · Q2
Source: Senate LDA
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry, including descriptions of corporate structure, business units, and data handling.
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry, including descriptions of corporate structure, business units, and data handling.
Prohibiting Foreign Access to American Genetic Information Act of 2024
Client: WUXI BIOLOGICS USA LLC · Firm: WUXI BIOLOGICS USA LLC
H.R. 7085 BIOSECURE ACT; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry.
Prohibiting Foreign Access to American Genetic Information Act of 2024
Client: WUXI BIOLOGICS USA LLC · Firm: WUXI BIOLOGICS USA LLC
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry, including descriptions of corporate structure, business units, and data handling.
Prohibiting Foreign Access to American Genetic Information Act of 2024
Client: WUXI BIOLOGICS USA LLC · Firm: WUXI BIOLOGICS USA LLC
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry, including descriptions of corporate structure, business units, and data handling.
Prohibiting Foreign Access to American Genetic Information Act of 2024
Client: WUXI BIOLOGICS USA LLC · Firm: WUXI BIOLOGICS USA LLC
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry, including descriptions of corporate structure, business units, and data handling.
Lobbying related to Congressional and Administration introductions and company updates, communications related to company operations and CRDMO industry, including descriptions of corporate structure, business units, and data handling.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
WUXI BIOLOGICS USA LLC via WUXI BIOLOGICS USA LLC
2026 · first_quarter · Q1
Lobbying related to Congressional and Administration introductions and company updates, communications related to company operations and CRDMO industry, including descriptions of corporate structure, business units, and data handling.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
WUXI BIOLOGICS USA LLC via WUXI BIOLOGICS USA LLC
2025 · fourth_quarter · Q4
Lobbying related to Congressional and Administration introductions and company updates, communications related to company operations and CRDMO industry, including descriptions of corporate structure, business units, and data handling.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
WUXI BIOLOGICS USA LLC via WUXI BIOLOGICS USA LLC
2025 · third_quarter · Q3
Lobbying related to Congressional and Administration introductions and company updates, communications related to company operations and CRDMO industry, including descriptions of corporate structure, business units, and data handling.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
WUXI BIOLOGICS USA LLC via WUXI BIOLOGICS USA LLC
2025 · second_quarter · Q2
Lobbying related to Congressional and Administration introductions and company updates, communications related to company operations and CRDMO industry, including descriptions of corporate structure, business units, and data handling.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
WUXI BIOLOGICS USA LLC via WUXI BIOLOGICS USA LLC
2025 · first_quarter · Q1
Lobbying related to Congressional and Administration introductions and company updates, communications related to company operations and CRDMO industry, including descriptions of corporate structure, business units, and data handling.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
WUXI BIOLOGICS USA LLC via WUXI BIOLOGICS USA LLC
2024 · fourth_quarter · Q4
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry, including descriptions of corporate structure, business units, and data handling.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
WUXI BIOLOGICS USA LLC via WUXI BIOLOGICS USA LLC
2024 · third_quarter · Q3
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry, including descriptions of corporate structure, business units, and data handling.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
WUXI BIOLOGICS USA LLC via WUXI BIOLOGICS USA LLC
2024 · second_quarter · Q2
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry, including descriptions of corporate structure, business units, and data handling.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
WUXI BIOLOGICS USA LLC via WUXI BIOLOGICS USA LLC
2024 · second_quarter · RR
H.R. 7085 BIOSECURE ACT; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry.